Wells Fargo & Company »

Iovance Biotherapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.8M 348k 8.13
2023-09-30 $2.4M 533k 4.55
2023-06-30 $2.7M 378k 7.04
2022-12-31 $242k 38k 6.39
2022-09-30 $579k 58k 9.93
2022-06-30 $310k 28k 11.12
2022-03-31 $868k 52k 16.66
2021-12-31 $1.1M 56k 20.20
2021-09-30 $1.2M 49k 24.62
2021-06-30 $1.5M 56k 26.52
2021-03-31 $1.9M 61k 31.64
2020-12-31 $3.4M 72k 46.41
2020-09-30 $3.8M 117k 32.93
2020-06-30 $4.5M 164k 27.44
2020-03-31 $3.2M 108k 29.93
2019-12-31 $6.8M 247k 27.68
2019-09-30 $3.6M 200k 18.20
2019-06-30 $4.6M 187k 24.53
2019-03-31 $3.6M 375k 9.51
2018-12-31 $2.1M 240k 8.84
2018-09-30 $1.8M 159k 11.26
2018-06-30 $1.1M 83k 12.80
2018-03-31 $927k 55k 16.90
2017-12-31 $399k 50k 7.99
2017-06-30 $528k 72k 7.35